Company research
Nuo Therapeutics, Inc.
CIK 1091596Updated Sep 27, 2026
SecurityAURX · OTC · equity
Name history
Nuo Therapeutics, Inc · through Dec 23, 2014CYTOMEDIX INC · through Oct 8, 2014AUTOLOGOUS WOUND THERAPY INC · through Apr 10, 2000AUTOLOGOUS WOUND TRERAPY INC · through Mar 23, 2000
AURX price & chart
Loading TradingView…
OTC:AURX on TradingView ↗In the news
No coverage from other publishers is available.
Recent filings
Results of Operations and Financial Condition
Items 2.02, 9.01
10-Q filing
SCHEDULE 13D/A - filed by Pittman Scott M. regarding Nuo Therapeutics, Inc.
Entry into a Material Definitive Agreement · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement · Unregistered Sales of Equity Securities
Items 1.01, 2.03, 3.02, 9.01
Results of Operations and Financial Condition
Items 2.02, 9.01
Financials
FY 2025 · USDSource
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 1,845,662Source | 1,189,508Source | 1,877,880Source | 3,047,360Source |
| Property, Plant and Equipment, NetUSD | 366,315Source | 177,022Source | 45,082Source | 53,165Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 548,946Source | 283,714Source | 928,681Source | 2,051,208Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 561,667Source | 248,205Source | 250,703Source | 92,320Source |
| Inventory, NetUSD | 213,761Source | 150,442Source | 209,589Source | 240,005Source |
| Assets, CurrentUSD | 1,379,883Source | 841,546Source | 1,563,444Source | 2,634,911Source |
| Prepaid Expense and Other Assets, CurrentUSD | 55,509Source | 159,185Source | 174,471Source | 196,378Source |
| Operating Lease, Right-of-Use AssetUSD | 99,464Source | 170,940Source | 269,354Source | 359,284Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 2,802,221Source | 675,796Source | 838,732Source | 856,022Source |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 4,818Source | 4,682Source | 4,424Source | 4,180Source |
| Additional Paid in CapitalUSD | 33,810,785Source | 32,768,976Source | 30,970,965Source | 28,951,963Source |
| Retained Earnings (Accumulated Deficit)USD | -34,772,162Source | -32,259,946Source | -29,936,241Source | -26,764,805Source |
| Stockholders' Equity Attributable to ParentUSD | -956,559Source | 513,712Source | 1,039,148Source | 2,191,338Source |
| Liabilities and EquityUSD | 1,845,662Source | 1,189,508Source | 1,877,880Source | 3,047,360Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 1,306,285Source | 578,451Source | 674,527Source | 600,431Source |
| Operating Lease, Liability, CurrentUSD | 76,410Source | 66,861Source | 91,387Source | 79,453Source |
| Accounts Payable, CurrentUSD | 436,083Source | 219,190Source | 394,518Source | 397,703Source |
| Operating Lease, Liability, NoncurrentUSD | 20,936Source | 97,345Source | 164,205Source | 255,592Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 493,792Source | 292,400Source | 188,622Source | 123,275Source |
| Deferred Revenue, CurrentUSD | 300,000Source | — | — | — |
| Deferred Revenue, NoncurrentUSD | 975,000Source | — | — | — |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | 85,986Source | 56,652Source | 21,746Source | 9,145Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | 404,863Source | 76,947Source | 318,383Source | 92,320Source |
| Increase (Decrease) in InventoriesUSD | 82,690Source | -29,147Source | -14,343Source | 240,005Source |
| Increase (Decrease) in Accounts PayableUSD | 216,893Source | -41,706Source | -3,185Source | 17,584Source |
| Deferred Income Tax Expense (Benefit)USD | 1,956,514Source | 515,619Source | -380,595Source | 1,591,563Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -864,971Source | -2,231,622Source | -3,167,782Source | -3,706,126Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -274,756Source | -154,962Source | -7,244Source | -59,992Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 274,756Source | 154,962Source | 7,244Source | 59,992Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 1,404,959Source | 1,741,617Source | 1,997,500Source | 4,457,757Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 265,232Source | -644,967Source | -1,177,527Source | 691,639Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 500,000Source | 300,000Source | 928,681Source | 2,106,208Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 4,721Source | 4,494Source | 4,003Source | 2,268Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 85,986Source | 56,652Source | 21,746Source | 9,145Source |
| DepreciationUSD | 85,463Source | 23,022Source | 15,327Source | 6,827Source |
| Income Tax Expense (Benefit)USD | 0Source | 0Source | 0Source | 0Source |
| Inventory Write-downUSD | 19,371Source | 30,000Source | 16,074Source | — |
| Net Income (Loss) Attributable to ParentUSD | -2,512,216Source | -2,323,705Source | -3,171,436Source | -3,171,736Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | -3,171,736Source |
| Operating ExpensesUSD | 4,734,605Source | 3,520,166Source | 3,650,707Source | 3,413,630Source |
| Operating Lease, ExpenseUSD | — | 86,600Source | 158,000Source | 128,000Source |
| Other Nonoperating Income (Expense)USD | 5,237Source | 402Source | 0Source | 4,523Source |
| Proceeds from Issuance of Common StockUSD | 791,418Source | 1,500,000Source | — | — |
| Proceeds from Stock Options ExercisedUSD | 113,541Source | 90,417Source | — | — |
| Revenue from Contract with Customer, Including Assessed TaxUSD | 3,313,509Source | 1,365,173Source | 608,525Source | 112,250Source |
| Unrealized Gain (Loss) on DerivativesUSD | — | — | — | 0Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cost of RevenueUSD | 1,095,553Source | 302,842Source | 126,092Source | 19,214Source |
| Selling, General and Administrative ExpenseUSD | 4,734,605Source | 3,520,166Source | 3,650,707Source | 3,413,630Source |
| Operating Income (Loss)USD | -2,516,649Source | -2,457,835Source | -3,168,274Source | -3,320,594Source |
| Other Nonoperating Income (Expense)USD | 5,237Source | 402Source | 0Source | 4,523Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -2,512,216Source | -2,323,705Source | -3,171,436Source | -3,171,736Source |
| Income Tax Expense (Benefit)USD | 0Source | 0Source | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | -2,512,216Source | -2,323,705Source | -3,171,436Source | -3,171,736Source |
| Earnings Per Share, BasicUSD per share | -0.05Source | -0.05Source | -0.08Source | -0.08Source |
| Total Revenue | — | — | — | — |
| Weighted Average Number of Shares Outstanding, Basicshares | 47,312,727Source | 45,424,437Source | 42,077,811Source | 40,001,089Source |
| Additional Financial Items | ||||
| Current Income Tax Expense (Benefit)USD | 0Source | 0Source | — | — |
| Gross ProfitUSD | 2,217,956Source | 1,062,331Source | 482,433Source | 93,036Source |
| Interest Income (Expense), Nonoperating, NetUSD | -804Source | 105Source | -3,162Source | -2,103Source |
| Labor and Related ExpenseUSD | 2,616,160Source | 2,029,762Source | — | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | -3,171,736Source |
| Operating ExpensesUSD | 4,734,605Source | 3,520,166Source | 3,650,707Source | 3,413,630Source |
| Operating Lease, ExpenseUSD | — | 86,600Source | 158,000Source | 128,000Source |
| Other Cost and Expense, OperatingUSD | 1,850,959Source | 1,265,579Source | — | — |
| Revenue from Contract with Customer, Including Assessed TaxUSD | 3,313,509Source | 1,365,173Source | 608,525Source | 112,250Source |